MALATHI, D. C.; JANAKIRAMAN, K.; THANGAVELU, S. V. A.; RAVICHANDRAN, D. Enlicitide (Lipfendra): the first oral PCSK9 inhibitor - from macrocyclic peptide innovation to clinical translation. International Journal of Basic & Clinical Pharmacology, [S. l.], v. 15, n. 5, p. 1126–1134, 2026. DOI: 10.18203/2319-2003.ijbcp20262890. Disponível em: https://www.ijbcp.com/index.php/ijbcp/article/view/6446. Acesso em: 25 aug. 2026.